Left ventricular global longitudinal strain in patients treated with immune checkpoint inhibitors
In our study, a reduction in LV GLS did not demonstrate a significant role in the early prediction of ICI-related myocarditis or cardiac dysfunction. Further validation through multicenter, large-scale, prospective studies with extended follow-up periods is needed to confirm these findings.
Authors
- Fatih Levent
- Ömer Furkan Demir (ORCID: https://orcid.org/0000-0002-0230-8442)
- Alper Çoşkun (ORCID: https://orcid.org/0000-0003-4745-5160)
- Ahmet Bilgehan Şahin (ORCID: https://orcid.org/0000-0002-7846-0870)
- Seda Sali
- Eyüp Çoban (ORCID: https://orcid.org/0000-0002-1618-8082)
- Erhan Tenekecioglu
- Türkkan Evrensel (ORCID: https://orcid.org/0000-0002-9732-5340)
- Fahriye Vatansever Ağca (ORCID: https://orcid.org/0000-0002-1401-2980)
- Adem Deligönül (ORCID: https://orcid.org/0000-0002-3669-6391)
- Ece Çelebi Coşkun (ORCID: https://orcid.org/0000-0002-0002-8578)
- Erdem Cubukcu
- Fatih Koca
Institutions
- Bursa Uludağ Üni̇versi̇tesi̇ (TR)
- University of Health Science (KH)
- Sağlık Bilimleri Üniversitesi (TR)
- S.B.Ü. Bursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi (TR)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-12-24
- DOI
- https://doi.org/10.3389/fonc.2024.1453721
- Citations
- 3
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.85